In a groundbreaking achievement, a closed-loop system leveraging AI, reported in the Journal of the Royal Society Interface, has identified potent drug combinations to target and eliminate cancer cells. This innovative approach involves experimental results guiding a machine learning model (LLM), whose outputs are then interpreted by human scientists to direct further experiments. While emphasizing that LLMs are not meant to replace scientists, researchers highlight their potential as supervised AI tools to enhance discovery in critical areas such as cancer research.
Read more from miragenews.com
